High amyloid levels linked to early-stage Alzheimer’s
By
Alicia Lasek
Apr 06, 2020
Screening data from an Alzheimer’s drug trial suggests that higher brain amyloid levels exist well before clinical symptoms appear.
FDA draft guidelines suggest route to approval for early-stage Alzheimer’s drugs
By
McKnight's Staff
Feb 11, 2013
The Food and Drug Administration issued draft guidance Thursday on clinical trials for early-stage Alzheimer’s drugs.
Study: New test might help diagnose Alzheimer’s earlier
Jun 24, 2011
A new test that measures amyloid levels in the spinal fluid of people with mild cognitive impairment could help physicians more accurately predict who will develop Alzheimer’s, a new study finds.